Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

121.

Delineating the mixed lineage leukemia gene expression network in hematopoietic stem cells.

Proc. Natl. Acad. Sci. U.S.A.
Luc S, Orkin SH.
| Jul 16, 2013
122.

Fat cells directly sense temperature to activate thermogenesis.

Proc. Natl. Acad. Sci. U.S.A.
Ye L, Wu J, Cohen P, Kazak L, Khandekar MJ, Jedrychowski MP, Zeng X, Gygi SP, Spiegelman BM.
| Jul 23, 2013
123.

Aspirin use and risk of colorectal cancer according to BRAF mutation status.

JAMA.
Nishihara R, Lochhead P, Kuchiba A, Jung S, Yamauchi M, Liao X, Imamura Y, Qian ZR, Morikawa T, Wang M, Spiegelman D, Cho E, Giovannucci E, Fuchs CS, Chan AT, Ogino S.
| Jun 26, 2013
124.

Model for macroevolutionary dynamics.

Proc. Natl. Acad. Sci. U.S.A.
Maruvka YE, Shnerb NM, Kessler DA, Ricklefs RE.
| Jul 2, 2013
125.

Molecular architecture of the uncleaved HIV-1 envelope glycoprotein trimer.

Proc. Natl. Acad. Sci. U.S.A.
Mao Y, Wang L, Gu C, Herschhorn A, Désormeaux A, Finzi A, Xiang SH, Sodroski JG.
| Jul 23, 2013
126.

Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer.

Proc. Natl. Acad. Sci. U.S.A.
Bowman-Colin C, Xia B, Bunting S, Klijn C, Drost R, Bouwman P, Fineman L, Chen X, Culhane AC, Cai H, Rodig SJ, Bronson RT, Jonkers J, Nussenzweig A, Kanellopoulou C, Livingston DM.
| May 21, 2013
127.

Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1.

Proc. Natl. Acad. Sci. U.S.A.
Ramkissoon LA, Horowitz PM, Craig JM, Ramkissoon SH, Rich BE, Schumacher SE, McKenna A, Lawrence MS, Bergthold G, Brastianos PK, Tabak B, Ducar MD, Van Hummelen P, MacConaill LE, Pouissant-Young T, Cho YJ, Taha H, Mahmoud M, Bowers DC, Margraf L, Tabori U, Hawkins C, Packer RJ, Hill DA, Pomeroy SL, Eberhart CG, Dunn IF, Goumnerova L, Getz G, Chan JA, Santagata S, Hahn WC, Stiles CD, Ligon AH, Kieran MW, Beroukhim R, Ligon KL.
| May 14, 2013
128.

Deciphering the rules of ceRNA networks.

Proc. Natl. Acad. Sci. U.S.A.
Cesana M, Daley GQ.
| Apr 30, 2013
129.

Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation.

Proc. Natl. Acad. Sci. U.S.A.
Jurado KA, Wang H, Slaughter A, Feng L, Kessl JJ, Koh Y, Wang W, Ballandras-Colas A, Patel PA, Fuchs JR, Kvaratskhelia M, Engelman A.
| May 21, 2013
130.

Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A.

Proc. Natl. Acad. Sci. U.S.A.
Xu J, Bauer DE, Kerenyi MA, Vo TD, Hou S, Hsu YJ, Yao H, Trowbridge JJ, Mandel G, Orkin SH.
| Apr 16, 2013
131.

Influence of metabolism on epigenetics and disease.

Cell.
Kaelin WG, McKnight SL.
| Mar 28, 2013
132.

Lessons from the cancer genome.

Cell.
Garraway LA, Lander ES.
| Mar 28, 2013
133.

Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway.

Nature.
Son J, Lyssiotis CA, Ying H, Wang X, Hua S, Ligorio M, Perera RM, Ferrone CR, Mullarky E, Shyh-Chang N, Kang Y, Fleming JB, Bardeesy N, Asara JM, Haigis MC, DePinho RA, Cantley LC, Kimmelman AC.
| Apr 4, 2013
134.

Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity.

Nat. Genet.
Dulak AM, Stojanov P, Peng S, Lawrence MS, Fox C, Stewart C, Bandla S, Imamura Y, Schumacher SE, Shefler E, McKenna A, Carter SL, Cibulskis K, Sivachenko A, Saksena G, Voet D, Ramos AH, Auclair D, Thompson K, Sougnez C, Onofrio RC, Guiducci C, Beroukhim R, Zhou Z, Lin L, Lin J, Reddy R, Chang A, Landrenau R, Pennathur A, Ogino S, Luketich JD, Golub TR, Gabriel SB, Lander ES, Beer DG, Godfrey TE, Getz G, Bass AJ.
| 03 24, 2013
135.

Chromatin remodeling at DNA double-strand breaks.

Cell.
Price BD, D'Andrea AD.
| Mar 14, 2013
136.

First-line treatment of indolent lymphoma: axing CHOP?

Lancet.
Jacobson CA, Freedman AS.
| Apr 6, 2013
137.

Evolution and impact of subclonal mutations in chronic lymphocytic leukemia.

Cell.
Landau DA, Carter SL, Stojanov P, McKenna A, Stevenson K, Lawrence MS, Sougnez C, Stewart C, Sivachenko A, Wang L, Wan Y, Zhang W, Shukla SA, Vartanov A, Fernandes SM, Saksena G, Cibulskis K, Tesar B, Gabriel S, Hacohen N, Meyerson M, Lander ES, Neuberg D, Brown JR, Getz G, Wu CJ.
| Feb 14, 2013
138.

Direct activation of full-length proapoptotic BAK.

Proc. Natl. Acad. Sci. U.S.A.
Leshchiner ES, Braun CR, Bird GH, Walensky LD.
| Mar 12, 2013
139.

(R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible.

Science.
Losman JA, Looper RE, Koivunen P, Lee S, Schneider RK, McMahon C, Cowley GS, Root DE, Ebert BL, Kaelin WG.
| Mar 29, 2013
140.

Service: an essential component of graduate medical education.

N. Engl. J. Med.
Kesselheim JC, Cassel CK.
| Feb 7, 2013